Clinical Trial Update: Study of High-Dose Resveratrol in Patients With Stable Ischemic Heart Disease [NA]

View source ↗

Summary

This update notes the completion of a clinical trial evaluating high-dose resveratrol in patients with stable ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Ischaemic Heart Desease | NA | Status: COMPLETED